These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32056929)

  • 1. Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR spectroscopic study.
    Draganov M; Vives-Gilabert Y; de Diego-Adeliño J; Vicent-Gil M; Puigdemont D; Portella MJ
    J Affect Disord; 2020 Apr; 266():572-577. PubMed ID: 32056929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy.
    Ritter C; Buchmann A; Müller ST; Volleberg M; Haynes M; Ghisleni C; Noeske R; Tuura R; Hasler G
    JAMA Psychiatry; 2022 Dec; 79(12):1209-1216. PubMed ID: 36260322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.
    Kantrowitz JT; Dong Z; Milak MS; Rashid R; Kegeles LS; Javitt DC; Lieberman JA; John Mann J
    Transl Psychiatry; 2021 Aug; 11(1):419. PubMed ID: 34354048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
    J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance (MR) spectroscopic measurement of γ-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy.
    Knudsen MK; Near J; Blicher AB; Videbech P; Blicher JU
    Acta Neuropsychiatr; 2019 Feb; 31(1):17-26. PubMed ID: 30079857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
    JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
    Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
    Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant chronotherapeutics normalizes prefrontal
    Melloni EMT; Bravi B; Poletti S; Dallaspezia S; Barbini B; Zanardi R; Benedetti F
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110606. PubMed ID: 35843368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
    Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
    Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rTMS on GABA and glutamate levels in treatment-resistant depression: An MR spectroscopy study.
    Godfrey KEM; Muthukumaraswamy SD; Stinear CM; Hoeh N
    Psychiatry Res Neuroimaging; 2021 Nov; 317():111377. PubMed ID: 34479176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T.
    Smith GS; Oeltzschner G; Gould NF; Leoutsakos JS; Nassery N; Joo JH; Kraut MA; Edden RAE; Barker PB; Wijtenburg SA; Rowland LM; Workman CI
    J Affect Disord; 2021 Jan; 279():417-425. PubMed ID: 33120242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis.
    Truong V; Cheng PZ; Lee HC; Lane TJ; Hsu TY; Duncan NW
    Psychiatry Res Neuroimaging; 2021 Feb; 308():111238. PubMed ID: 33385764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
    Godfrey KEM; Gardner AC; Kwon S; Chea W; Muthukumaraswamy SD
    J Psychiatr Res; 2018 Oct; 105():33-44. PubMed ID: 30144668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.
    Zhang X; Tang Y; Maletic-Savatic M; Sheng J; Zhang X; Zhu Y; Zhang T; Wang J; Tong S; Wang J; Li Y
    J Affect Disord; 2016 Sep; 201():153-61. PubMed ID: 27235818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Benson KL; Bottary R; Schoerning L; Baer L; Gonenc A; Eric Jensen J; Winkelman JW
    J Affect Disord; 2020 Sep; 274():624-631. PubMed ID: 32663996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.
    Murck H; Schubert MI; Schmid D; Schüssler P; Steiger A; Auer DP
    J Psychiatr Res; 2009 Jan; 43(3):175-80. PubMed ID: 18533184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.